The purpose of this study was to investigate the serum levels of CXCL-13, RBP-4, and IL-6 in patients with Graves' disease and to analyze the correlation between serum CXCL-13, RBP-4, and IL-6 levels and the basal metabolic rate (BMR). This evidence concerns the gene IL6 and Graves disease.